The global Recombinant Proteins Market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $3.2 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key...
The Recombinant Proteins Market, valued at USD 2.4 billion in 2022, is projected to grow significantly in the coming years. By 2030, the market is expected to reach USD 5.8 billion, expanding at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2023-2030. Recombinant proteins, produced through recombinant DNA technology, play a crucial role in various...
Recombinant proteins play a crucial role in various biopharmaceutical applications, contributing significantly to the production of therapeutic drugs and vaccines. These biotherapeutics, produced through advanced biochemical techniques involving the transfer of genetic material across organisms, are instrumental in large-scale manufacturing of essential therapeutic proteins, including insulin,...
Recombinant proteins play a crucial role in various biopharmaceutical applications, contributing significantly to the production of therapeutic drugs and vaccines. These biotherapeutics, produced through advanced biochemical techniques involving the transfer of genetic material across organisms, are instrumental in large-scale manufacturing of essential therapeutic proteins, including insulin,...
The Recombinant Proteins Market is projected to reach USD 3.2 Billion by 2028 from USD 2.2 Billion in 2023, at a CAGR of 7.2% during the forecast period. Growth in the recombinant proteins market can be attributed to factors such as rising incidence of chronic diseases, increasing demand for biologics and biosimilars due to patent expirations, increasing government support for R&D and...